Effective 3/23/2022
4-41a-602. Cannabis product — Labeling and child-resistant packaging.
4-41a-602. Cannabis product — Labeling and child-resistant packaging.
- (1) For any cannabis product that a cannabis processing facility processes or produces and for any raw cannabis that the facility packages, the facility shall:
- (a) label the cannabis or cannabis product with a label that:
- (i) clearly and unambiguously states that the cannabis product or package contains cannabis;
- (ii) clearly displays the amount of total composite tetrahydrocannabinol, cannabidiol, and any known cannabinoid described in Subsection 4-41a-701(4) in the labeled container;
- (iii) has a unique identification number that:
- (A) is connected to the inventory control system; and
- (B) identifies the unique cannabis product manufacturing process the cannabis processing facility used to manufacture the cannabis product;
- (iv) identifies the cannabinoid extraction process that the cannabis processing facility used to create the cannabis product;
- (v) does not display an image, word, or phrase that the facility knows or should know appeals to children; and
- (vi) discloses each active or potentially active ingredient, in order of prominence, and possible allergen; and
- (b) package the raw cannabis or cannabis product in a medicinal dosage form in a container that:
- (i) is tamper evident and tamper resistant;
- (ii) does not appeal to children;
- (iii) does not mimic a candy container;
- (iv) complies with child-resistant effectiveness standards that the United States Consumer Product Safety Commission establishes; and
- (v) includes a warning label that states:
- (A) for a container labeled before July 1, 2021, “WARNING: Cannabis has intoxicating effects and may be addictive. Do not operate a vehicle or machinery under its influence. KEEP OUT OF REACH OF CHILDREN. This product is for medical use only. Use only as directed by a qualified medical provider.”; or
- (B) for a container labeled on or after July 1, 2021, “WARNING: Cannabis has intoxicating effects and may be addictive. Do not operate a vehicle or machinery under its influence. KEEP OUT OF REACH OF CHILDREN. This product is for medical use only. Use only as directed by a recommending medical provider.”.
- (a) label the cannabis or cannabis product with a label that:
- (2) For any cannabis or cannabis product that the cannabis processing facility processes into a gelatinous cube, gelatinous rectangular cuboid, or lozenge in a cube or rectangular cuboid shape, the facility shall:
- (a) ensure that the label described in Subsection (1)(a) does not contain a photograph or other image of the content of the container; and
- (b) include on the label described in Subsection (1)(a) a warning about the risks of over-consumption.
- (3) For any cannabis product that contains any derivative cannabinoid or synthetic cannabinoid, the cannabis processing facility shall ensure that the label clearly:
- (a) identifies each derivative cannabinoid or synthetic cannabinoid; and
- (b) identifies that each derivative or synthetic cannabinoid is a derivative or synthetic cannabinoid.
- (4) In accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, the department:
- (a) shall make rules to establish:
- (i) a standard labeling format that:
- (A) complies with the requirements of this section; and
- (B) ensures inclusion of a pharmacy label; and
- (ii) additional requirements on packaging for cannabis and cannabis products to ensure safety and product quality; and
- (i) a standard labeling format that:
- (b) may make rules to further define standards regarding images, words, phrases, or containers that may appeal to children under Subsection (1)(a)(v) or (1)(b)(ii).
- (a) shall make rules to establish:
Amended by Chapter 290, 2022 General Session
Amended by Chapter 337, 2021 General Session
Amended by Chapter 350, 2021 General Session